Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers

Published:2023 Issue: Volume: Page:155-204
ISSN:0065-2423
Container-title:Advances in Clinical Chemistry
language:
Short-container-title:

Author:

Kurose Koji,Sakaeda Kanako,Fukuda Minoru,Sakai Yumiko,Yamaguchi Hiroyuki,Takemoto Shinnosuke,Shimizu Katsuhiko,Masuda Takeshi,Nakatomi Katsumi,Kawase Shigeo,Tanaka Ryo,Suetsugu Takayuki,Mizuno Keiko,Hasegawa Takehiro,Atarashi Yusuke,Irino Yasuhiro,Sato Toshiyuki,Inoue Hiromasa,Hattori Noboru,Kanda Eiichiro,Nakata Masao,Mukae Hiroshi,Oga Toru,Oka Mikio

Publisher

Elsevier

Reference134 articles.

1. Lung cancer;Thai;Lancet,2021

2. Toward personalized treatment approaches for non-small-cell lung cancer;Wang;Nat. Med.,2021

3. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade;Morad;Cell,2021

4. First-line immunotherapy for non-small-cell lung cancer;Reck;J. Clin. Oncol.,2022

5. Immunotherapy for advanced non-small cell lung cancer: a decade of progress;Shields;Am. Soc. Clin. Oncol. Educ. Book,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of CT-based radiomics for the prediction of immune checkpoint markers and immunotherapeutic outcomes in non-small cell lung cancer;Frontiers in Immunology;2024-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP